Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-06-24 Sale | 2024-07-08 4:30 pm | GENELUX Corp | GNLX | Yu Yong VP, Clinical Trial Operations | 6,849 | $2.12 | $14,520 | 10,869 (Direct) | View |
| 2024-05-29 Purchase | 2024-06-07 9:40 pm | GENELUX Corp | GNLX | Yu Yong VP, Clinical Trial Operations | 2,500 | $0 | $0 | 5,000 (Direct) | View |
| 2023-12-15 Sale | 2023-12-18 4:15 pm | GENELUX Corp | GNLX | Yu Yong VP, Clinical Trial Operations | 32,535 | $13.16 | $428,180 | 0 (Direct) | View |
| 2023-12-07 Sale | 2023-12-08 5:57 pm | GENELUX Corp | GNLX | Yu Yong VP, Clinical Trial Operations | 36,800 | $11.85 | $435,995 | 32,535 (Direct) | View |
| 2023-11-21 Sale | 2023-11-22 4:15 pm | GENELUX Corp | GNLX | Yu Yong VP, Clinical Trial Operations | 18,665 | $10.26 | $191,555 | 69,335 (Direct) | View |
| 2023-11-17 Sale | 2023-11-21 4:15 pm | GENELUX Corp | GNLX | Yu Yong VP, Clinical Trial Operations | 18,135 | $11.6 | $210,431 | 88,000 (Direct) | View |
| 2023-10-24 Sale | 2023-10-25 4:15 pm | GENELUX Corp | GNLX | Yu Yong VP, Clinical Trial Operations | 5,200 | $19.11 | $99,351 | 313,788 (Direct) | View |
| 2023-10-10 Sale | 2023-10-11 4:10 pm | GENELUX Corp | GNLX | Yu Yong VP, Clinical Trial Operations | 5,200 | $22.01 | $114,462 | 318,988 (Direct) | View |
| 2023-09-26 Sale | 2023-09-27 4:10 pm | GENELUX Corp | GNLX | Yu Yong VP, Clinical Trial Operations | 5,200 | $23.56 | $122,528 | 324,188 (Direct) | View |
| 2023-09-20 Sale | 2023-09-21 4:35 pm | GENELUX Corp | GNLX | Yu Yong VP, Clinical Trial Operations | 6,000 | $27.96 | $167,786 | 329,388 (Direct) | View |
| 2023-09-15 Sale | 2023-09-18 8:13 pm | GENELUX Corp | GNLX | Yu Yong VP, Clinical Trial Operations | 10,400 | $21.89 | $227,630 | 335,388 (Direct) | View |
| 2023-09-13 Sale | 2023-09-15 8:06 pm | GENELUX Corp | GNLX | Yu Yong VP, Clinical Trial Operations | 29,800 | $21.14 | $629,927 | 106,135 (Direct) | View |
| 2023-08-30 Sale | 2023-08-30 7:22 pm | GENELUX Corp | GNLX | Yu Yong VP, Clinical Trial Operations | 19,800 | $24.7 | $489,060 | 135,935 (Direct) | View |
| 2023-08-18 Sale | 2023-08-22 4:14 pm | GENELUX Corp | GNLX | Yu Yong VP, Clinical Trial Operations | 3,265 | $23.73 | $77,478 | 155,735 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-19 Option Award | 2024-07-08 4:30 pm | N/A N/A | GENELUX Corp | GNLX | Yu Yong VP, Clinical Trial Operations | 15,218 | $0 | 10,869 (Direct) | View |
| 2023-10-24 Exercise | 2023-10-25 4:15 pm | N/A 2029-09-20 | GENELUX Corp | GNLX | Yu Yong VP, Clinical Trial Operations | 5,200 | $0 | 313,788 (Direct) | View |
| 2023-10-24 Exercise | 2023-10-25 4:15 pm | N/A N/A | GENELUX Corp | GNLX | Yu Yong VP, Clinical Trial Operations | 5,200 | $6 | 313,788 (Direct) | View |
| 2023-10-10 Exercise | 2023-10-11 4:10 pm | N/A 2029-09-20 | GENELUX Corp | GNLX | Yu Yong VP, Clinical Trial Operations | 5,200 | $0 | 318,988 (Direct) | View |
| 2023-10-10 Exercise | 2023-10-11 4:10 pm | N/A N/A | GENELUX Corp | GNLX | Yu Yong VP, Clinical Trial Operations | 5,200 | $6 | 318,988 (Direct) | View |
| 2023-09-26 Exercise | 2023-09-27 4:10 pm | N/A 2029-09-20 | GENELUX Corp | GNLX | Yu Yong VP, Clinical Trial Operations | 5,200 | $0 | 324,188 (Direct) | View |
| 2023-09-26 Exercise | 2023-09-27 4:10 pm | N/A N/A | GENELUX Corp | GNLX | Yu Yong VP, Clinical Trial Operations | 5,200 | $6 | 324,188 (Direct) | View |
| 2023-09-20 Exercise | 2023-09-21 4:35 pm | N/A 2029-09-20 | GENELUX Corp | GNLX | Yu Yong VP, Clinical Trial Operations | 6,000 | $0 | 329,388 (Direct) | View |
| 2023-09-20 Exercise | 2023-09-21 4:35 pm | N/A N/A | GENELUX Corp | GNLX | Yu Yong VP, Clinical Trial Operations | 6,000 | $6 | 329,388 (Direct) | View |
| 2023-09-15 Exercise | 2023-09-18 8:13 pm | N/A 2029-09-20 | GENELUX Corp | GNLX | Yu Yong VP, Clinical Trial Operations | 10,400 | $0 | 335,388 (Direct) | View |
| 2023-09-15 Exercise | 2023-09-18 8:13 pm | N/A N/A | GENELUX Corp | GNLX | Yu Yong VP, Clinical Trial Operations | 10,400 | $6 | 335,388 (Direct) | View |
| 2023-09-11 Option Award | 2023-09-12 4:24 pm | N/A 2033-09-10 | GENELUX Corp | GNLX | Yu Yong VP, Clinical Trial Operations | 65,000 | $0 | 65,000 (Direct) | View |
| 2023-02-17 Option Award | 2023-05-02 4:22 pm | N/A N/A | GENELUX CORP | GNLX | Yu Tony VP, Clinical Trial Operations | 9,000 | $0 | 159,000 (Direct) | View |
Ownership | 2023-01-25 7:23 pm | N/A N/A | GENELUX CORP | GNLX | Yu Tony VP, Clinical Trial Operations | 0 | $0 | 389,653 (Direct) | View |